Andrew Hirsch
Chief Executive Officer presso C4 THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Andrew J.
Hirsch is currently the President, Chief Executive Officer & Director at C4 Therapeutics, Inc. since 2020.
He is also an Independent Director at Editas Medicine, Inc. since 2017.
Previously, he held positions such as President, CEO, CAO & Director at DNIB Unwind, Inc. from 2012 to 2016, VP-Corporate Strategy, Mergers & Acquisitions at Biogen, Inc. from 2002 to 2011, CFO & Head-Corporate Development at Agios Pharmaceuticals, Inc. from 2016 to 2020, and Chief Financial Officer at Avila Therapeutics, Inc. from 2011 to 2012.
Mr. Hirsch completed his undergraduate degree at the University of Pennsylvania in 1992 and obtained an MBA from the Tuck School of Business at Dartmouth in 1997.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.31% | 15/02/2024 | 210 741 ( 0.31% ) | 2 M $ | 31/03/2024 |
EDITAS MEDICINE, INC.
0.00% | 01/06/2023 | 2 000 ( 0.00% ) | 14 840 $ | 31/03/2024 |
Posizioni attive di Andrew Hirsch
| Società | Posizione | Inizio |
|---|---|---|
| EDITAS MEDICINE, INC. | Director/Board Member | 30/05/2017 |
| C4 THERAPEUTICS, INC. | Chief Executive Officer | 02/10/2020 |
Precedenti posizioni note di Andrew Hirsch
| Società | Posizione | Fine |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director of Finance/CFO | 11/09/2020 |
| DNIB UNWIND INC | Chief Executive Officer | 24/07/2016 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Director of Finance/CFO | 31/03/2012 |
| BIOGEN INC. | Corporate Officer/Principal | 01/06/2011 |
Formazione di Andrew Hirsch
| University of Pennsylvania | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Andrew Hirsch
